DashboardPortfoliosWatchlistCommunityDiscoverScreener
NOT FOR DISTRIBUTION
Loading...
  • Stocks
  • /
  • Materials
Updated 5h ago
CRDA logo

Croda International PlcLSE:CRDA Stock Report

Market Cap UK£4.4b
Updated 5h ago
Share Price
n/a
1Y16.7%
7D-0.4%
1D-1.4%
Portfolio Value
​
View

Croda International Plc

LSE:CRDA Stock Report

Market Cap: UK£4.4b

  • Company Overview
    • Valuation
    • Future Growth
    • Past Performance
    • Financial Health
    • Dividend
  • Management
  • Ownership
  • Other Information
  • Stock Community

Croda International (CRDA) Stock Overview

Engages in the consumer care, life science, and industrial specialty businesses in Europe, the Middle East, Africa, North America, Asia, and Latin America. More details

CRDA fundamental analysis
Snowflake Score
Valuation2/6
Future Growth4/6
Past Performance1/6
Financial Health6/6
Dividends4/6

Rewards

Trading at 21.6% below our estimate of its fair value

Earnings are forecast to grow 22.85% per year

Risk Analysis

Profit margins (4.6%) are lower than last year (8.4%)

Dividend of 3.51% is not well covered by earnings


CRDA Community Fair Values

Create Narrative

See what 48 others think this stock is worth. Follow their fair value or set your own to get alerts.

Analyst Price Targets

AN
AnalystConsensusTarget
11.6% undervalued intrinsic discount
AnalystConsensusTarget
•3mo ago

CRDA: Activist Pressure And Sector Outlook Will Drive Share Performance This Year

316
0
26
AN
AnalystHighTarget
26.4% undervalued intrinsic discount
AnalystHighTarget
•1mo ago

Sustainable Biotech Ingredients Will Capture Global Specialty Demand

139
0
4
AN
AnalystLowTarget
Fairly Valued intrinsic discount
AnalystLowTarget
•1mo ago

Rising Regulation Will Threaten Specialty Chemicals Though Tailwinds Remain

49
0
0

Top Analyst Narratives

AN
AnalystConsensusTarget
11.6% undervalued intrinsic discount
AnalystConsensusTarget
•3mo ago

CRDA: Activist Pressure And Sector Outlook Will Drive Share Performance This Year

316
0
26
AN
AnalystHighTarget
26.4% undervalued intrinsic discount
AnalystHighTarget
•1mo ago

Sustainable Biotech Ingredients Will Capture Global Specialty Demand

139
0
4
AN
AnalystLowTarget
Fairly Valued intrinsic discount
AnalystLowTarget
•1mo ago

Rising Regulation Will Threaten Specialty Chemicals Though Tailwinds Remain

49
0
0
View all narratives

Croda International Plc Competitors

Elementis

Symbol: LSE:ELM
Market cap: UK£967.1m

Iofina

Symbol: AIM:IOF
Market cap: UK£97.8m

Hardide

Symbol: AIM:HDD
Market cap: UK£70.9m

Hill & Smith

Symbol: LSE:HILS
Market cap: UK£2.4b

Price History & Performance

Summary of share price highs, lows and changes for Croda International
Historical stock prices
Current Share PriceUK£31.63
52 Week HighUK£35.20
52 Week LowUK£24.88
Beta0.93
1 Month Change-7.86%
3 Month Change1.64%
1 Year Change16.67%
3 Year Change-35.91%
5 Year Change-64.22%
Change since IPO1,874.32%

Recent News & Updates

User avatar
Narrative Update • Aug 12

CRDA: Gradual Broker Revisions And Execution Risks Will Shape Future P/E Repricing

Croda International's implied fair value has increased from £28.65 to £31.90. Analysts attribute this change to revised assumptions around revenue growth, profitability and future P/E expectations, which support a higher long-term price target and align with recent upward revisions from several covering firms.
User avatar
Narrative Update • Jul 29

CRDA: Recent Repricing Signals Future Re Rating Potential At 3,400 Level

The updated analyst price target for Croda International is now £3,400, up £50 from the prior £3,350, as analysts reflect revised fair value assumptions alongside slightly lower revenue growth and profit margin forecasts and a modestly adjusted future P/E multiple. Analyst Commentary Recent research updates on Croda International point to a more constructive tone from bullish analysts, who are refining their valuation work rather than making sweeping changes to their investment cases.

Recent updates

User avatar
Narrative Update • Aug 12

CRDA: Gradual Broker Revisions And Execution Risks Will Shape Future P/E Repricing

Croda International's implied fair value has increased from £28.65 to £31.90. Analysts attribute this change to revised assumptions around revenue growth, profitability and future P/E expectations, which support a higher long-term price target and align with recent upward revisions from several covering firms.
User avatar
Narrative Update • Jul 29

CRDA: Recent Repricing Signals Future Re Rating Potential At 3,400 Level

The updated analyst price target for Croda International is now £3,400, up £50 from the prior £3,350, as analysts reflect revised fair value assumptions alongside slightly lower revenue growth and profit margin forecasts and a modestly adjusted future P/E multiple. Analyst Commentary Recent research updates on Croda International point to a more constructive tone from bullish analysts, who are refining their valuation work rather than making sweeping changes to their investment cases.
User avatar
Narrative Update • Jun 16

CRDA: Mixed Broker Revisions And Execution Risks Will Shape Future P/E Path

Croda International's analyst price targets have shifted higher to £32.00 from £30.00, as analysts cite updated assumptions around revenue growth, profit margins and a slightly lower discount rate, along with a modestly adjusted future P/E expectation. Analyst Commentary Recent research on Croda International highlights a mix of optimism and caution, with several firms adjusting ratings and price targets as they reassess the company’s growth prospects, profit outlook and valuation framework.
User avatar
Narrative Update • Jun 02

CRDA: Margin Execution And Multiple Support Will Drive Reappraisal Over Time

Analysts have lifted their price target on Croda International by around £1, reflecting slightly higher fair value estimates, modestly adjusted revenue growth and margin assumptions, and a small change in expected future P/E multiples following a series of recent upgrades offset by at least one target cut. Analyst Commentary Bullish Takeaways Bullish analysts have upgraded Croda International, indicating greater confidence that the current share price may not fully reflect their revised fair value estimates.
User avatar
Narrative Update • May 17

CRDA: Mixed Broker Upgrades And Execution Risks Will Shape Future P/E Expectations

Analysts have adjusted their price targets on Croda International to around £32.80. This reflects updated assumptions on revenue growth, profit margins and future P/E multiples following a series of recent rating upgrades and target tweaks across the Street.
User avatar
Narrative Update • May 01

CRDA: Cluster Of Recent Upgrades Will Support Re Rating Potential

The updated analysis trims Croda International's fair value estimate slightly to £47.67 from £47.96, as analysts factor in recent target changes and upgrades that reflect adjusted assumptions for revenue growth, profit margins, and future P/E multiples. Analyst Commentary Recent Street research on Croda International has leaned constructive, with several bullish analysts adjusting ratings and targets in quick succession.
User avatar
Narrative Update • Apr 17

CRDA: Mixed Broker Upgrades And Execution Risks Will Shape Fair Value Outlook

Analysts have raised their fair value estimate for Croda International from £23.00 to £28.65, citing recent upgrades, higher price targets, and updated assumptions for revenue growth, profit margins, and future P/E multiples. Analyst Commentary Recent Street research on Croda International shows a mix of supportive and cautious views, with several firms revisiting their ratings and price targets in quick succession.
User avatar
Narrative Update • Apr 02

CRDA: Recent Upgrades And Higher 3,280 Price Level Will Support Re Rating

Analysts have nudged their fair value estimate for Croda International slightly lower to about £47.96 from £48.16, reflecting modest adjustments to discount rate, revenue growth, profit margin and future P/E assumptions, alongside mixed but generally constructive recent research, including both target cuts and upgrades. Analyst Commentary Recent Street research on Croda International has leaned constructive, with several bullish analysts updating their views through rating changes and revised price targets.
User avatar
Narrative Update • Mar 19

CRDA: Higher Price Move To 3,280 And Modest P/E Reset Signal Upside

Narrative Update The analyst price target for Croda International has been raised to £3,280, an increase of £250. Analysts reference recent target moves from major banks, along with small adjustments to revenue growth, profit margin, discount rate and future P/E assumptions.
User avatar
Narrative Update • Mar 05

CRDA: Higher Price References And Modest P/E Reset Will Support Upside Potential

Narrative Update The analyst price target for Croda International has been raised. Our fair value estimate has moved slightly higher to reflect recent increases in Street targets to around £32 per share, supported by analysts pointing to updated assumptions on discount rates, revenue growth, profit margins and future P/E expectations.
User avatar
Narrative Update • Feb 19

CRDA: Higher Fair Value Assumptions Will Drive Reappraisal Of Margin Resilience

Analysts have raised their price target on Croda International by £4.00. This reflects updated assumptions for fair value, discount rate, revenue growth, profit margins, and future P/E following recent research updates.
User avatar
Narrative Update • Feb 05

CRDA: Refined Assumptions And Lower P/E Will Support Higher Share Price

Analysts have trimmed their price target for Croda International by a small amount, reflecting updated views on fair value, discount rate, revenue growth, profit margin and future P/E assumptions. Valuation Changes Fair Value: trimmed slightly from £48.67 to £48.04 per share.
User avatar
Narrative Update • Jan 21

CRDA: Activist Pressure Will Drive Reappraisal Of Margin Resilience And Future Re Rating

Analysts have trimmed their price target for Croda International to £34.02 from £34.46, reflecting slightly more cautious assumptions on revenue growth and profit margin, along with a modestly higher discount rate and a higher future P/E multiple. Valuation Changes Fair Value Estimate: trimmed slightly to £34.02 from £34.46.
Analysis Article • Jan 21

Is There An Opportunity With Croda International Plc's (LON:CRDA) 26% Undervaluation?

Key Insights Croda International's estimated fair value is UK£35.97 based on 2 Stage Free Cash Flow to Equity Current...
User avatar
Narrative Update • Jan 06

CRDA: Refreshed Q4 Guidance And Earnings Outlook Will Support Higher Share Price

Croda International's updated analyst price target has moved slightly higher, with recent revisions in the range of £30.50 to £33.00 per share, supported by analysts' refreshed assumptions for fair value, discount rate, revenue growth, profit margin and future P/E. Analyst Commentary Recent research shows a cluster of modestly higher fair value views for Croda International, with price targets in a relatively tight range of £30.50 to £33.00 per share.
Analysis Article • Jan 06

Croda International Plc's (LON:CRDA) Popularity With Investors Is Clear

With a price-to-earnings (or "P/E") ratio of 27.2x Croda International Plc ( LON:CRDA ) may be sending very bearish...
User avatar
Narrative Update • Dec 17

CRDA: Activist Pressure Will Drive Future Reappraisal Of Margin Resilience

The analyst price target for Croda International has edged higher to approximately £31.00. This reflects modest improvements in forecast growth and valuation multiples as analysts point to stabilizing end markets and potential upside from strategic and activist driven initiatives, despite mixed target revisions across the Street.
Analysis Article • Dec 05

Should You Investigate Croda International Plc (LON:CRDA) At UK£26.70?

Croda International Plc ( LON:CRDA ), is not the largest company out there, but it received a lot of attention from a...
User avatar
Narrative Update • Dec 03

CRDA: Activist Pressure Will Drive A Reappraisal Of Margin Resilience

Analysts have nudged up their price target on Croda International by about £1, placing it in the low £30s per share. They point to a stabilizing outlook, reflected in modestly higher Street targets and expectations that prior commoditization concerns may have been overstated.
Analysis Article • Nov 20

Is Croda International (LON:CRDA) Using Too Much Debt?

The external fund manager backed by Berkshire Hathaway's Charlie Munger, Li Lu, makes no bones about it when he says...
User avatar
Narrative Update • Nov 18

CRDA: Activist Pressure And Commoditization Concerns Will Shape The Next Share Move

Croda International's analyst price target has seen a modest upward revision to 3,150 GBp from 3,000 GBp. This reflects analysts' view that recent sector updates and firm-specific catalysts support a slightly higher fair value for the shares. Analyst Commentary Recent research updates on Croda International have highlighted a mix of optimism and caution.
User avatar
Narrative Update • Nov 03

CRDA: Activist Pressure And Sector Outlook Will Drive Share Performance This Year

Croda International's analyst price target has been modestly raised, with the new consensus target increasing to approximately £31.00 from £30.00. Analysts cite slight improvements in revenue growth expectations and a lower discount rate as reasons for the update.
User avatar
Narrative Update • Oct 20

Sustainable Bio-Based Chemicals Will Expand In Asia And Latin America

Croda International's analyst consensus price target has seen a modest uptick, rising by £0.50 to £31.00. Analysts cite improved profit margins as offsetting softer revenue growth expectations.
Analysis Article • Oct 06

Croda International (LON:CRDA) Will Be Hoping To Turn Its Returns On Capital Around

To find a multi-bagger stock, what are the underlying trends we should look for in a business? In a perfect world, we'd...
User avatar
Narrative Update • Oct 03

Sustainable Bio-Based Chemicals Will Expand In Asia And Latin America

Analysts have revised Croda International's price target downward from £36.00 to £31.00, citing shifts in fair value and an improving revenue growth outlook. Ongoing activist pressures are seen as a potential positive for shares despite persistent margin concerns.
User avatar
Narrative Update • Sep 14

Sustainable Bio-Based Chemicals Will Expand In Asia And Latin America

Croda International’s consensus price target saw a modest reduction to £35.23 as both future P/E and revenue growth expectations remained stable. What's in the News Croda International is prioritizing organic investment with a focus on higher returns, risk management, and faster cash payback, while reducing CapEx as a percentage of sales from 2026 onwards.
User avatar
New Narrative • Mar 02

Acquisition Of Solus Biotech And Asian Expansion Will Strengthen Future Outlook

Strengthening local relationships and strategic acquisitions, particularly in Asia, should drive revenue through higher prices and increased manufacturing capacity.

Shareholder Returns

CRDAGB ChemicalsGB Market
7D-0.4%0.4%0.04%
1Y16.7%8.0%15.9%

Return vs Industry: CRDA exceeded the UK Chemicals industry which returned 8% over the past year.

Return vs Market: CRDA matched the UK Market which returned 15.9% over the past year.

Price Volatility

Is CRDA's price volatile compared to industry and market?
CRDA volatility
CRDA Average Weekly Movement4.5%
Chemicals Industry Average Movement6.6%
Market Average Movement4.9%
10% most volatile stocks in GB Market10.8%
10% least volatile stocks in GB Market2.6%

Stable Share Price: CRDA has not had significant price volatility in the past 3 months compared to the UK market.

Volatility Over Time: CRDA's weekly volatility (4%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
19255,954Steve Footswww.croda.com

Croda International Plc engages in the consumer care, life science, and industrial specialty businesses in Europe, the Middle East, Africa, North America, Asia, and Latin America. The company offers consumer care products across beauty care, beauty actives, and home care products, as well as fragrances and flavours. It also provides biologics drug delivery, crop protection, and seed coating systems and enhancement technologies to improve germination.

Croda International Plc Fundamentals Summary

How do Croda International's earnings and revenue compare to its market cap?
CRDA fundamental statistics
Market capUK£4.43b
Earnings (TTM)UK£79.50m
Revenue (TTM)UK£1.72b
55.7x
P/E Ratio
2.6x
P/S Ratio

Is CRDA overvalued?

See Fair Value and valuation analysis

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
CRDA income statement (TTM)
RevenueUK£1.72b
Cost of RevenueUK£970.80m
Gross ProfitUK£753.30m
Other ExpensesUK£673.80m
EarningsUK£79.50m

Last Reported Earnings

Jun 30, 2026

Next Earnings Date

Feb 23, 2027

Earnings per share (EPS)0.57
Gross Margin43.69%
Net Profit Margin4.61%
Debt/Equity Ratio32.2%

How did CRDA perform over the long term?

See historical performance and comparison

Dividends

3.5%
Current Dividend Yield
194%
Payout Ratio

Does CRDA pay a reliable dividends?

See CRDA dividend history and benchmarks
When do you need to buy CRDA by to receive an upcoming dividend?
Croda International dividend dates
Ex Dividend DateAug 27 2026
Dividend Pay DateOct 06 2026
Days until Ex dividend24 days
Days until Dividend pay date16 days

Does CRDA pay a reliable dividends?

See CRDA dividend history and benchmarks

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2026/09/20 01:08
End of Day Share Price 2026/09/18 00:00
Earnings2026/06/30
Annual Earnings2025/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
  • SEC Form 10-K
  • SEC Form 10-Q
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
  • Analyst Research Reports
  • Blue Matrix
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
  • ICE Market Data
  • SEC Form S-1
Ownership10 years
  • Top shareholders
  • Insider trading
  • SEC Form 4
  • SEC Form 13D
Management10 years
  • Leadership team
  • Board of directors
  • SEC Form 10-K
  • SEC Form DEF 14A
Key Developments10 years
  • Company announcements
  • SEC Form 8-K

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Croda International Plc is covered by 34 analysts. 12 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
James KnightBarclays
Katie RichardsBarclays
Amy LianBarclays

Make Better Investing Decisions Anywhere

Scan to download
Open AppStoreOpen Google Play
Chrome Web Store
Level 5, 320 Pitt Street, Sydney
Financial Data provided by S&P Global Market Intelligence LLC, analysis provided by Simply Wall Street Pty Ltd. Copyright © 2026, S&P Global Market Intelligence LLC. All rights reserved.
View Data Sources
Markets
  • US: NYSE & NASDAQ
  • UK: FTSE
  • Australia: ASX
  • India: NIFTY
  • Canada: TSX
  • South Africa: JSE
  • Japan: NIKKEI
  • South Korea: KOSPI
  • Germany: DAX
Investing Ideas
  • Undervalued Companies
  • Dividend Powerhouses
  • Insider Buying
  • Nuclear Energy
  • Autonomous Vehicles
  • Artificial Intelligence
  • Crypto and Blockchain
  • Cybersecurity
  • More ideas
Stock Communities
  • AstraZeneca
  • HSBC Holdings
  • Shell
  • Unilever
  • Diageo
  • Rio Tinto Group
  • RELX
  • BP
  • Barclays
Features & Tools
  • Portfolio Tracker
  • Stock Screener & Alerts
  • Narratives & Fair Values
  • Dividend Calculator
News & Discovery
  • Latest Stock News
  • Global Market Insights
  • The Foxhole
  • Investing Ideas
  • Community Narratives
  • What's New
Simply Wall St
  • Plans & Pricing
  • Advertising
  • About Us
  • Contact Us
  • Careers
  • Help Center
  • Learn Stock Investing
  • Affiliate Program
  • Business & Enterprise
  • Charlie AI
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.
© 2026 Simply Wall Street Pty Ltd, US Design Patent #29/544/281, Community and European Design Registration #2845206
  • Terms and Conditions
  • Privacy Policy
  • AI Terms
  • Financial Services Guide